National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 348843

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

348843
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:0000-00-00
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available.


Changed on 1/5/2010

348843 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:0000-00-00 2008-08-01
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None None; Family history of diabetes
Allergies:
Diagnostic Lab Data: Unknown Unknown; diagnostic laboratory test, 26Aug08, 26.1, Diabetic acidosis ABB; arterial blood pCO(2), 26Aug08, 16.7; arterial blood pH, 26Aug08, 7.04; plasma HCO(3), 26Aug08, 44.8; serum blood urea, 26Aug08, 6.7; serum creatinine, 26Aug08, 117;
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available. Follow up has been received on 16-JUN-2009. The hospital report was provided. The patient was hospitalized from 26-AUG-2008 until 12-SEP-2008. Hospital diagnosis: "Manifestation of diabetes mellitus type I with ketoacidosis and precoma diabeticum". Since a "few weeks before hospitalization" the patient experienced polydipsia and polyuria and lost 7 kg of weight. Since about 2 weeks before hospitalization her general condition began to reduce. Since one week she suffered from angina tonsillaris which was treated with antibiotics. Symptoms worsened remarkably and she was hospitalized on 26-AUG-2008. At the time the patient was slightly drowsy (Glasgow coma scale 14) showed Kussmaul respiration and signs of exsiccosis Hyperglycemia (27 mmol/L) had been determined by the physician on emergency. Therapy was started with rehydratation and insulin intravenous. Intensive insulin therapy (LANTUS and NOVORAPID) was started from the third day of hospitalization. In the course of the quantity of insulin could be measurably reduced. In the meantime the patient developed a pruritic, partly urticarial rash which was successfully treated with FENYSTIL. Lab findings see lab comments: Gliadin-IgA and Gliadin-IgG, tTG(endomysium) Ig A were normal. The patient had a family Medical history of Diabetes mellitus type 2 (maternal grand father). The patient was discharged in a good general condition. Duration and outc


Changed on 7/31/2010

348843 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:2008-08-01
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Acute tonsillitis, Blood bicarbonate increased, Blood creatinine increased, Blood glucose decreased, Blood immunoglobulin A, Blood immunoglobulin A normal, Blood immunoglobulin G normal, Blood osmolarity increased, Blood pH decreased, Blood urea normal, Diabetic ketoacidosis, Glycosylated haemoglobin, Ketoacidosis, PCO2 decreased, Polydipsia, Polyuria, Protein total increased, Rash pruritic, Somnolence, Tri-iodothyronine decreased, Urine analysis, Urticaria, Weight decreased, General physical health deterioration, Urine ketone body present, Antibody test normal, Familial risk factor, Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None; Family history of diabetes
Allergies:
Diagnostic Lab Data: Unknown; diagnostic laboratory test, 26Aug08, 26.1, Diabetic acidosis ABB; arterial blood pCO(2), 26Aug08, 16.7; arterial blood pH, 26Aug08, 7.04; plasma HCO(3), 26Aug08, 44.8; serum blood urea, 26Aug08, 6.7; serum creatinine, 26Aug08, 117;
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available. Follow up has been received on 16-JUN-2009. The hospital report was provided. The patient was hospitalized from 26-AUG-2008 until 12-SEP-2008. Hospital diagnosis: "Manifestation of diabetes mellitus type I with ketoacidosis and precoma diabeticum". Since a "few weeks before hospitalization" the patient experienced polydipsia and polyuria and lost 7 kg of weight. Since about 2 weeks before hospitalization her general condition began to reduce. Since one week she suffered from angina tonsillaris which was treated with antibiotics. Symptoms worsened remarkably and she was hospitalized on 26-AUG-2008. At the time the patient was slightly drowsy (Glasgow coma scale 14) showed Kussmaul respiration and signs of exsiccosis Hyperglycemia (27 mmol/L) had been determined by the physician on emergency. Therapy was started with rehydratation and insulin intravenous. Intensive insulin therapy (LANTUS and NOVORAPID) was started from the third day of hospitalization. In the course of the quantity of insulin could be measurably reduced. In the meantime the patient developed a pruritic, partly urticarial rash which was successfully treated with FENYSTIL. Lab findings see lab comments: Gliadin-IgA and Gliadin-IgG, tTG(endomysium) Ig A were normal. The patient had a family Medical history of Diabetes mellitus type 2 (maternal grand father). The patient was discharged in a good general condition. Duration and outc


Changed on 8/31/2010

348843 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:2008-08-01
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Acute tonsillitis, Blood bicarbonate increased, Blood creatinine increased, Blood glucose decreased, Blood immunoglobulin A, Blood immunoglobulin A normal, Blood immunoglobulin G normal, Blood osmolarity increased, Blood pH decreased, Blood urea normal, Diabetes mellitus insulin-dependent, Diabetic ketoacidosis, Glycosylated haemoglobin, Ketoacidosis, PCO2 decreased, Polydipsia, Polyuria, Protein total increased, Rash pruritic, Somnolence, Tri-iodothyronine decreased, Urine analysis, Urticaria, Weight decreased, General physical health deterioration, Urine ketone body present, Antibody test normal, Familial risk factor, Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None; Family history of diabetes
Allergies:
Diagnostic Lab Data: Unknown; diagnostic laboratory test, 26Aug08, 26.1, Diabetic acidosis ABB; arterial blood pCO(2), 26Aug08, 16.7; arterial blood pH, 26Aug08, 7.04; plasma HCO(3), 26Aug08, 44.8; serum blood urea, 26Aug08, 6.7; serum creatinine, 26Aug08, 117;
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available. Follow up has been received on 16-JUN-2009. The hospital report was provided. The patient was hospitalized from 26-AUG-2008 until 12-SEP-2008. Hospital diagnosis: "Manifestation of diabetes mellitus type I with ketoacidosis and precoma diabeticum". Since a "few weeks before hospitalization" the patient experienced polydipsia and polyuria and lost 7 kg of weight. Since about 2 weeks before hospitalization her general condition began to reduce. Since one week she suffered from angina tonsillaris which was treated with antibiotics. Symptoms worsened remarkably and she was hospitalized on 26-AUG-2008. At the time the patient was slightly drowsy (Glasgow coma scale 14) showed Kussmaul respiration and signs of exsiccosis Hyperglycemia (27 mmol/L) had been determined by the physician on emergency. Therapy was started with rehydratation and insulin intravenous. Intensive insulin therapy (LANTUS and NOVORAPID) was started from the third day of hospitalization. In the course of the quantity of insulin could be measurably reduced. In the meantime the patient developed a pruritic, partly urticarial rash which was successfully treated with FENYSTIL. Lab findings see lab comments: Gliadin-IgA and Gliadin-IgG, tTG(endomysium) Ig A were normal. The patient had a family Medical history of Diabetes mellitus type 2 (maternal grand father). The patient was discharged in a good general condition. Duration and outc


Changed on 1/4/2011

348843 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:2008-08-01
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Acute tonsillitis, Blood bicarbonate increased, Blood creatinine increased, Blood glucose decreased, Blood immunoglobulin A, Blood immunoglobulin A normal, Blood immunoglobulin G normal, Blood osmolarity increased, Blood pH decreased, Blood urea normal, Diabetes mellitus insulin-dependent, Diabetic ketoacidosis, Glycosylated haemoglobin, Ketoacidosis, PCO2 decreased, Polydipsia, Polyuria, Protein total increased, Rash pruritic, Somnolence, Tri-iodothyronine decreased, Urine analysis, Urticaria, Weight decreased, General physical health deterioration, Urine ketone body present, Antibody test normal, Familial risk factor, Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None; Family history of diabetes
Allergies:
Diagnostic Lab Data: Unknown; diagnostic laboratory test, 26Aug08, 26.1, Diabetic acidosis ABB; arterial blood pCO(2), 26Aug08, 16.7; arterial blood pH, 26Aug08, 7.04; plasma HCO(3), 26Aug08, 44.8; serum blood urea, 26Aug08, 6.7; serum creatinine, 26Aug08, 117; serum glucose, 26Aug08, 27 mmol/L; serum glucose, 26Aug08, 34.6; total serum protein, 26Aug08, 75; urinalysis, 26Aug08, Glucose increased; urinalysis, 26Aug08, Protein increased; urinalysis, keton possitive; whole blood glycosylated hemoglobin, 26Aug08, 7.0; free serum triodothyronine test, 26Aug08, 2.2 pmol/L; serum osmolality test, 26Aug08, 324; whole blood glycosylated hemoglobin, 08Sep08, 10.5; serum gliadin IgA antibody, 10Sep08, Normal; serum gliadin IgG antibody, 10Sep08, Normal; serum glucose, 10
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available. Follow up has been received on 16-JUN-2009. The hospital report was provided. The patient was hospitalized from 26-AUG-2008 until 12-SEP-2008. Hospital diagnosis: "Manifestation of diabetes mellitus type I with ketoacidosis and precoma diabeticum". Since a "few weeks before hospitalization" the patient experienced polydipsia and polyuria and lost 7 kg of weight. Since about 2 weeks before hospitalization her general condition began to reduce. Since one week she suffered from angina tonsillaris which was treated with antibiotics. Symptoms worsened remarkably and she was hospitalized on 26-AUG-2008. At the time the patient was slightly drowsy (Glasgow coma scale 14) showed Kussmaul respiration and signs of exsiccosis Hyperglycemia (27 mmol/L) had been determined by the physician on emergency. Therapy was started with rehydratation and insulin intravenous. Intensive insulin therapy (LANTUS and NOVORAPID) was started from the third day of hospitalization. In the course of the quantity of insulin could be measurably reduced. In the meantime the patient developed a pruritic, partly urticarial rash which was successfully treated with FENYSTIL. Lab findings see lab comments: Gliadin-IgA and Gliadin-IgG, tTG(endomysium) Ig A were normal. The patient had a family Medical history of Diabetes mellitus type 2 (maternal grand father). The patient was discharged in a good general condition. Duration and outc outcome was not reported for each symptom. This is an amended report. Information received date was updated in the narrative from 16-JAN-2009 to 16-JUN-2009. Gliadin-IgM was changed to Gliadin-IgG and lab data field was updated. File is closed. No further information is available. This is a corrected report, as amended.


Changed on 6/14/2014

348843 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:2008-08-01
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Acute tonsillitis, Blood bicarbonate increased, Blood creatinine increased, Blood glucose decreased, Blood immunoglobulin A, Blood immunoglobulin A normal, Blood immunoglobulin G normal, Blood osmolarity increased, Blood pH decreased, Blood urea normal, Diabetic ketoacidosis, Glycosylated haemoglobin, Ketoacidosis, PCO2 decreased, Polydipsia, Polyuria, Protein total increased, Rash pruritic, Somnolence, Tri-iodothyronine decreased, Urine analysis, Urticaria, Weight decreased, General physical health deterioration, Urine ketone body present, Antibody test normal, Familial risk factor, Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None; Family history of diabetes
Allergies:
Diagnostic Lab Data: Unknown; diagnostic laboratory test, 26Aug08, 26.1, Diabetic acidosis ABB; arterial blood pCO(2), 26Aug08, 16.7; arterial blood pH, 26Aug08, 7.04; plasma HCO(3), 26Aug08, 44.8; serum blood urea, 26Aug08, 6.7; serum creatinine, 26Aug08, 117; serum glucose, 26Aug08, 27 mmol/L; serum glucose, 26Aug08, 34.6; total serum protein, 26Aug08, 75; urinalysis, 26Aug08, Glucose increased; urinalysis, 26Aug08, Protein increased; urinalysis, keton possitive; whole blood glycosylated hemoglobin, 26Aug08, 7.0; free serum triodothyronine test, 26Aug08, 2.2 pmol/L; serum osmolality test, 26Aug08, 324; whole blood glycosylated hemoglobin, 08Sep08, 10.5; serum gliadin IgA antibody, 10Sep08, Normal; serum gliadin IgG antibody, 10Sep08, Normal; serum glucose, 10
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available. Follow up has been received on 16-JUN-2009. The hospital report was provided. The patient was hospitalized from 26-AUG-2008 until 12-SEP-2008. Hospital diagnosis: "Manifestation of diabetes mellitus type I with ketoacidosis and precoma diabeticum". Since a "few weeks before hospitalization" the patient experienced polydipsia and polyuria and lost 7 kg of weight. Since about 2 weeks before hospitalization her general condition began to reduce. Since one week she suffered from angina tonsillaris which was treated with antibiotics. Symptoms worsened remarkably and she was hospitalized on 26-AUG-2008. At the time the patient was slightly drowsy (Glasgow coma scale 14) showed Kussmaul respiration and signs of exsiccosis Hyperglycemia (27 mmol/L) had been determined by the physician on emergency. Therapy was started with rehydratation and insulin intravenous. Intensive insulin therapy (LANTUS and NOVORAPID) was started from the third day of hospitalization. In the course of the quantity of insulin could be measurably reduced. In the meantime the patient developed a pruritic, partly urticarial rash which was successfully treated with FENYSTIL. Lab findings see lab comments: Gliadin-IgA and Gliadin-IgG, tTG(endomysium) Ig A were normal. The patient had a family Medical history of Diabetes mellitus type 2 (maternal grand father). The patient was discharged in a good general condition. Duration and outcome was not reported for each symptom. This is an amended report. Information received date was updated in the narrative from 16-JAN-2009 to 16-JUN-2009. Gliadin-IgM was changed to Gliadin-IgG and lab data field was updated. File is closed. No further information is available. This is a corrected report, as amended.


Changed on 4/14/2017

348843 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:2008-08-01
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Acute tonsillitis, Blood bicarbonate increased, Blood creatinine increased, Blood glucose decreased, Blood immunoglobulin A, Blood immunoglobulin A normal, Blood immunoglobulin G normal, Blood osmolarity increased, Blood pH decreased, Blood urea normal, Diabetic ketoacidosis, Glycosylated haemoglobin, Ketoacidosis, PCO2 decreased, Polydipsia, Polyuria, Protein total increased, Rash pruritic, Somnolence, Tri-iodothyronine decreased, Urine analysis, Urticaria, Weight decreased, General physical health deterioration, Urine ketone body present, Antibody test normal, Familial risk factor, Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None; Family history of diabetes
Allergies:
Diagnostic Lab Data: Unknown; diagnostic laboratory test, 26Aug08, 26.1, Diabetic acidosis ABB; arterial blood pCO(2), 26Aug08, 16.7; arterial blood pH, 26Aug08, 7.04; plasma HCO(3), 26Aug08, 44.8; serum blood urea, 26Aug08, 6.7; serum creatinine, 26Aug08, 117; serum glucose, 26Aug08, 27 mmol/L; serum glucose, 26Aug08, 34.6; total serum protein, 26Aug08, 75; urinalysis, 26Aug08, Glucose increased; urinalysis, 26Aug08, Protein increased; urinalysis, keton possitive; whole blood glycosylated hemoglobin, 26Aug08, 7.0; free serum triodothyronine test, 26Aug08, 2.2 pmol/L; serum osmolality test, 26Aug08, 324; whole blood glycosylated hemoglobin, 08Sep08, 10.5; serum gliadin IgA antibody, 10Sep08, Normal; serum gliadin IgG antibody, 10Sep08, Normal; serum glucose, 10
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available. Follow up has been received on 16-JUN-2009. The hospital report was provided. The patient was hospitalized from 26-AUG-2008 until 12-SEP-2008. Hospital diagnosis: "Manifestation of diabetes mellitus type I with ketoacidosis and precoma diabeticum". Since a "few weeks before hospitalization" the patient experienced polydipsia and polyuria and lost 7 kg of weight. Since about 2 weeks before hospitalization her general condition began to reduce. Since one week she suffered from angina tonsillaris which was treated with antibiotics. Symptoms worsened remarkably and she was hospitalized on 26-AUG-2008. At the time the patient was slightly drowsy (Glasgow coma scale 14) showed Kussmaul respiration and signs of exsiccosis Hyperglycemia (27 mmol/L) had been determined by the physician on emergency. Therapy was started with rehydratation and insulin intravenous. Intensive insulin therapy (LANTUS and NOVORAPID) was started from the third day of hospitalization. In the course of the quantity of insulin could be measurably reduced. In the meantime the patient developed a pruritic, partly urticarial rash which was successfully treated with FENYSTIL. Lab findings see lab comments: Gliadin-IgA and Gliadin-IgG, tTG(endomysium) Ig A were normal. The patient had a family Medical history of Diabetes mellitus type 2 (maternal grand father). The patient was discharged in a good general condition. Duration and outcome was not reported for each symptom. This is an amended report. Information received date was updated in the narrative from 16-JAN-2009 to 16-JUN-2009. Gliadin-IgM was changed to Gliadin-IgG and lab data field was updated. File is closed. No further information is available. This is a corrected report, as amended.


Changed on 9/14/2017

348843 Before After
VAERS Form:(blank) 1
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2008-02-06
Onset:2008-08-01
Submitted:2009-06-09
Entered:2009-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 1 UN / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Acute tonsillitis, Blood bicarbonate increased, Blood creatinine increased, Blood glucose decreased, Blood immunoglobulin A, Blood immunoglobulin A normal, Blood immunoglobulin G normal, Blood osmolarity increased, Blood pH decreased, Blood urea normal, Diabetic ketoacidosis, Glycosylated haemoglobin, Ketoacidosis, PCO2 decreased, Polydipsia, Polyuria, Protein total increased, Rash pruritic, Somnolence, Tri-iodothyronine decreased, Urine analysis, Urticaria, Weight decreased, General physical health deterioration, Urine ketone body present, Antibody test normal, Familial risk factor, Type 1 diabetes mellitus

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None; Family history of diabetes
Allergies:
Diagnostic Lab Data: Unknown; diagnostic laboratory test, 26Aug08, 26.1, Diabetic acidosis ABB; arterial blood pCO(2), 26Aug08, 16.7; arterial blood pH, 26Aug08, 7.04; plasma HCO(3), 26Aug08, 44.8; serum blood urea, 26Aug08, 6.7; serum creatinine, 26Aug08, 117; serum glucose, 26Aug08, 27 mmol/L; serum glucose, 26Aug08, 34.6; total serum protein, 26Aug08, 75; urinalysis, 26Aug08, Glucose increased; urinalysis, 26Aug08, Protein increased; urinalysis, keton possitive; whole blood glycosylated hemoglobin, 26Aug08, 7.0; free serum triodothyronine test, 26Aug08, 2.2 pmol/L; serum osmolality test, 26Aug08, 324; whole blood glycosylated hemoglobin, 08Sep08, 10.5; serum gliadin IgA antibody, 10Sep08, Normal; serum gliadin IgG antibody, 10Sep08, Normal; serum glucose, 10 10Sep08, 5.7 mmol/L; serum tissue transglutaminase IgA, 10Sep08, Normal; serum immunoglobulin A test, 10Sep08, Normal
CDC 'Split Type': WAES0906USA00947

Write-up:Information has been received from a gynecologist that a 14 year old female patient who was vaccinated IM with a first dose of GARDASIL (lot number and injection site not reported) on 06-FEB-2008. On unspecified date ("in a temporal relationship to GARDASIL vaccination"), the patient developed diabetes mellitus type I. The patient had not recovered at the time of reporting. Upon internal review on 04-JUN-2009, the case was considered medically significant. Type I diabetes mellitus was considered to be disabling by the gynecologist. Other business partner numbers included (E2009-04463). No further information is available. Follow up has been received on 16-JUN-2009. The hospital report was provided. The patient was hospitalized from 26-AUG-2008 until 12-SEP-2008. Hospital diagnosis: "Manifestation of diabetes mellitus type I with ketoacidosis and precoma diabeticum". Since a "few weeks before hospitalization" the patient experienced polydipsia and polyuria and lost 7 kg of weight. Since about 2 weeks before hospitalization her general condition began to reduce. Since one week she suffered from angina tonsillaris which was treated with antibiotics. Symptoms worsened remarkably and she was hospitalized on 26-AUG-2008. At the time the patient was slightly drowsy (Glasgow coma scale 14) showed Kussmaul respiration and signs of exsiccosis Hyperglycemia (27 mmol/L) had been determined by the physician on emergency. Therapy was started with rehydratation and insulin intravenous. Intensive insulin therapy (LANTUS and NOVORAPID) was started from the third day of hospitalization. In the course of the quantity of insulin could be measurably reduced. In the meantime the patient developed a pruritic, partly urticarial rash which was successfully treated with FENYSTIL. Lab findings see lab comments: Gliadin-IgA and Gliadin-IgG, tTG(endomysium) Ig A were normal. The patient had a family Medical history of Diabetes mellitus type 2 (maternal grand father). The patient was discharged in a good general condition. Duration and outcome was not reported for each symptom. This is an amended report. Information received date was updated in the narrative from 16-JAN-2009 to 16-JUN-2009. Gliadin-IgM was changed to Gliadin-IgG and lab data field was updated. File is closed. No further information is available. This is a corrected report, as amended.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=348843&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166